Recombinant Human HDAC6 Protein, MYC/DDK-tagged, C13 and N15-labeled
Cat.No. : | HDAC6-111H |
Product Overview : | HDAC6 MS Standard C13 and N15-labeled recombinant protein (NP_006035) with a C-terminal MYC/DDK tag, was expressed in HEK293 cells. |
- Specification
- Gene Information
- Related Products
Description : | Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to class II of the histone deacetylase/acuc/apha family. It contains an internal duplication of two catalytic domains which appear to function independently of each other. This protein possesses histone deacetylase activity and represses transcription. |
Source : | HEK293 |
Species : | Human |
Tag : | Myc/DDK |
Molecular Mass : | 131.2 kDa |
AA Sequence : | MTSTGQDSTTTRQRRSRQNPQSPPQ DSSVTSKRNIKKGAVPRSIPNLAEV KKKGKMKKLGQAMEEDLIVGLQGMD LNLEAEALAGTGLVLDEQLNEFHCL WDDSFPEGPERLHAIKEQLIQEGLL DRCVSFQARFAEKEELMLVHSLEYI DLMETTQYMNEGELRVLADTYDSVY LHPNSYSCACLASGSVLRLVDAVLG AEIRNGMAIIRPPGHHAQHSLMDGY CMFNHVAVAARYAQQKHRIRRVLIV DWDVHHGQGTQFTFDQDPSVLYFSI HRYEQGRFWPHLKASNWSTTGFGQG QGYTINVPWNQVGMRDADYIAAFLH VLLPVALEFQPQLVLVAAGFDALQG DPKGEMAATPAGFAQLTHLLMGLAG GKLILSLEGGYNLRALAEGVSASLH TLLGDPCPMLESPGAPCRSAQASVS CALEALEPFWEVLVRSTETVERDNM EEDNVEESEEEGPWEPPVLPILTWP VLQSRTGLVYDQNMMNHCNLWDSHH PEVPQRILRIMCRLEELGLAGRCLT LTPRPATEAELLTCHSAEYVGHLRA TEKMKTRELHRESSNFDSIYICPST FACAQLATGAACRLVEAVLSGEVLN GAAVVRPPGHHAEQDAACGFCFFNS VAVAARHAQTISGHALRILIVDWDV HHGNGTQHMFEDDPSVLYVSLHRYD HGTFFPMGDEGASSQIGRAAGTGFT VNVAWNGPRMGDADYLAAWHRLVLP IAYEFNPELVLVSAGFDAARGDPLG GCQVSPEGYAHLTHLLMGLASGRII LILEGGYNLTSISESMAACTRSLLG DPPPLLTLPRPPLSGALASITETIQ VHRRYWRSLRVMKVEDREGPSSSKL VTKKAPQPAKPRLAERMTTREKKVL EAGMGKVTSASFGEESTPGQTNSET AVVALTQDQPSEAATGGATLAQTIS EAAIGGAMLGQTTSEEAVGGATPDQ TTSEETVGGAILDQTTSEDAVGGAT LGQTTSEEAVGGATLAQTTSEAAME GATLDQTTSEEAPGGTELIQTPLAS STDHQTPPTSPVQGTTPQISPSTLI GSLRTLELGSESQGASESQAPGEEN LLGEAAGGQDMADSMLMQGSRGLTD QAIFYAVTPLPWCPHLVAVCPIPAA GLDVTQPCGDCGTIQENWVCLSCYQ VYCGRYINGHMLQHHGNSGHPLVLS YIDLSAWCYYCQAYVHHQALLDVKD IAHQNKFGEDMPHPHTRTRPLEQKL ISEEDLAANDILDYKDDDDKV |
Purity : | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Stability : | Stable for 3 months from receipt of products under proper storage and handling conditions. |
Storage : | Store at -80 centigrade. Avoid repeated freeze-thaw cycles. |
Concentration : | 50 μg/mL as determined by BCA |
Storage Buffer : | 100 mM glycine, 25 mM Tris-HCl, pH 7.3. |
Gene Name : | HDAC6 histone deacetylase 6 [ Homo sapiens (human) ] |
Official Symbol : | HDAC6 |
Synonyms : | HDAC6; histone deacetylase 6; CPBHM; HD6; JM21; PPP1R90; histone deacetylase 6; protein phosphatase 1, regulatory subunit 90; tubulin-lysine deacetylase HDAC6; NP_001308154.1; EC 3.5.1.98 |
Gene ID : | 10013 |
mRNA Refseq : | NM_006044 |
Protein Refseq : | NP_006035 |
MIM : | 300272 |
UniProt ID : | Q9UBN7 |
Products Types
◆ Recombinant Protein | ||
HDAC6-4092M | Recombinant Mouse HDAC6 Protein, His (Fc)-Avi-tagged | +Inquiry |
HDAC6-41H | Recombinant Human HDAC6 Protein, GST-tagged | +Inquiry |
HDAC6-2236H | Recombinant Human HDAC6 Protein, His-tagged | +Inquiry |
HDAC6-1055H | Recombinant Human HDAC6 Protein, His (Fc)-Avi-tagged | +Inquiry |
HDAC6-096H | Recombinant Human HDAC6 Protein, GST-tagged | +Inquiry |
◆ Lysates | ||
HDAC6-5603HCL | Recombinant Human HDAC6 293 Cell Lysate | +Inquiry |
◆ Assay kits | ||
Kit-1742 | HDAC6 Fluorogenic Assay Kit | +Inquiry |
Kit-1028 | HDAC6 Activity Assay Kit (Fluorometric) | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionYes, HDAC6 inhibitors can be combined with other therapies for enhanced efficacy. Synergistic effects may include improved anti-cancer activity or neuroprotection.
Yes, there are clinical trials exploring HDAC6 inhibitors as potential treatments. Positive outcomes could lead to new therapeutic options for patients.
HDAC6 is implicated in neurodegenerative diseases and inflammatory disorders. Understanding its role could lead to novel therapeutic approaches for these conditions.
HDAC6 regulates cell motility, protein trafficking, and other processes. Understanding these mechanisms is crucial for developing targeted therapies in various diseases.
Genetic variations in HDAC6 may influence individual responses to treatments. Personalized medicine approaches could consider these variations for better outcomes.
Customer Reviews (3)
Write a reviewTheir expertise and guidance have helped overcome hurdles, ensuring the smooth progress of my research.
The bands of proteins in Western Blotting experiments were very clear.
Its purity and consistency have provided me with reliable and reproducible results, ensuring the accuracy of my research findings.
Ask a Question for All HDAC6 Products
Required fields are marked with *
My Review for All HDAC6 Products
Required fields are marked with *
Inquiry Basket